Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 2Breast Neoplasms 2Smoldering Multiple Myeloma 1Psychological Well-Being 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Helicobacter Infections 1Fatigue Syndrome, Chronic 1Esophageal Neoplasms 1Diarrhea 1Breast Carcinoma In Situ 1

Interventions

Oxaliplatin 42Fluorouracil 27Capecitabine 24pembrolizumab 21S 1 (combination) 19Paclitaxel 19Leucovorin 16Nivolumab 13Docetaxel 13sintilimab 12Drug Therapy 12Trastuzumab 11tislelizumab 10Cisplatin 10Irinotecan 9Bevacizumab 8trastuzumab deruxtecan 7spartalizumab 7XELOX 7Surgical Procedures, Operative 7Radiotherapy 7Hyperthermic Intraperitoneal Chemotherapy 7Biopsy 7fludarabine 6disitamab vedotin 6Cyclophosphamide 6lenvatinib 5apatinib 5Specimen Handling 5Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Stomach Neoplasms × Probiotics × Clear all
NCT04871412 2026-01-30

POISE

Ottawa Hospital Research Institute

Phase 3 Recruiting
20 enrolled
GastrointestinalThoracic

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

NCT06186089 2024-04-11

Effect of Gastrectomy on Gut Microbiome and Cognitive Function

Tongji Hospital

Recruiting
45 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡